Young-Chae Chang Selected Research

Atherosclerosis

1/2021	Avenanthramide C Suppresses Matrix Metalloproteinase-9 Expression and Migration Through the MAPK/NF- κB Signaling Pathway in TNF-α-Activated HASMC Cells.
1/2015	p21WAF1 Is Required for Interleukin-16-Induced Migration and Invasion of Vascular Smooth Muscle Cells via the p38MAPK/Sp-1/MMP-9 Pathway.
5/2013	Comparative proteome analysis of Tumor necrosis factor α-stimulated human Vascular Smooth Muscle Cells in response to melittin.
8/2012	Pimaric acid from Aralia cordata has an inhibitory effect on TNF-α-induced MMP-9 production and HASMC migration via down-regulated NF-κB and AP-1.
1/2010	Bee venom reduces atherosclerotic lesion formation via anti-inflammatory mechanism.
7/2009	Deoxypodophyllotoxin, flavolignan, from Anthriscus sylvestris Hoffm. inhibits migration and MMP-9 via MAPK pathways in TNF-alpha-induced HASMC.
12/2006	Cryptotanshinone from Salvia miltiorrhiza BUNGE has an inhibitory effect on TNF-alpha-induced matrix metalloproteinase-9 production and HASMC migration via down-regulated NF-kappaB and AP-1.
12/2006	The ascochlorin derivative, AS-6, inhibits TNF-alpha-induced adhesion molecule and chemokine expression in rat vascular smooth muscle cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Young-Chae Chang Research Topics

Disease

46	Neoplasms (Cancer) 04/2024 - 10/2003
14	Neoplasm Metastasis (Metastasis) 01/2019 - 11/2004
13	Inflammation (Inflammations) 01/2021 - 02/2004
12	Fibrosis (Cirrhosis) 12/2014 - 05/2004
9	Breast Neoplasms (Breast Cancer) 01/2017 - 04/2005
8	Atherosclerosis 01/2021 - 12/2006
8	Lung Neoplasms (Lung Cancer) 08/2020 - 08/2012
7	Carcinoma (Carcinomatosis) 07/2022 - 11/2007
7	Osteosarcoma (Osteogenic Sarcoma) 12/2019 - 06/2004
6	Hypoxia (Hypoxemia) 01/2024 - 03/2011
6	Leukemia 10/2020 - 05/2008
6	Hepatocellular Carcinoma (Hepatoma) 05/2019 - 02/2004
6	Insulin Resistance 05/2013 - 02/2008
5	Arthritis (Polyarthritis) 04/2015 - 07/2003
4	Pain (Aches) 05/2013 - 03/2007
4	Rheumatoid Arthritis 05/2013 - 12/2006
3	Hypertension (High Blood Pressure) 01/2021 - 10/2006
3	Urinary Bladder Neoplasms (Bladder Cancer) 08/2019 - 01/2013
3	Glioma (Gliomas) 12/2017 - 05/2009
3	Anaphylaxis (Anaphylactic Shock) 01/2017 - 12/2011
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017 - 08/2008
3	Ureteral Obstruction 10/2013 - 08/2006
3	Type 2 Diabetes Mellitus (MODY) 05/2013 - 02/2008
3	Bone Resorption 08/2004 - 08/2003
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2022 - 01/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 09/2018
2	Arteriosclerosis 01/2021 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 12/2013
2	Rheumatic Diseases (Rheumatism) 04/2015 - 01/2013
2	Skin Diseases (Skin Disease) 04/2015 - 07/2014
2	Liver Diseases (Liver Disease) 12/2014 - 05/2004
2	Liver Cirrhosis (Hepatic Cirrhosis) 08/2014 - 05/2006
2	Colonic Neoplasms (Colon Cancer) 01/2014 - 06/2009
2	Experimental Arthritis 12/2008 - 09/2006
2	Neuroblastoma 04/2005 - 12/2003
2	Carcinogenesis 11/2004 - 02/2004

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 10/2020 - 05/2006
15	ascochlorinIBA 10/2020 - 04/2005
12	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 08/2003
12	Bee Venoms (Bee Venom)IBA 01/2019 - 12/2006
11	Anti-Bacterial Agents (Antibiotics)IBA 10/2020 - 11/2007
10	CytokinesIBA 01/2021 - 08/2003
9	Melitten (Melittin)IBA 01/2021 - 02/2010
8	ascofuranoneIBA 10/2020 - 09/2008
7	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2019 - 07/2005
5	Epidermal Growth Factor (EGF)IBA 08/2020 - 01/2013
5	Transcription Factors (Transcription Factor)IBA 12/2019 - 11/2007
5	Antineoplastic Agents (Antineoplastics)IBA 07/2019 - 03/2011
5	Terpenes (Terpenoids)IBA 01/2018 - 09/2008
5	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2017 - 04/2005
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2015 - 08/2003
5	NF-kappa B (NF-kB)IBA 04/2015 - 11/2004
4	4-O-methylascochlorinIBA 10/2020 - 03/2011
4	4-O-carboxymethylascochlorinIBA 02/2019 - 12/2006
4	AMP-Activated Protein KinasesIBA 01/2017 - 06/2010
4	Peptides (Polypeptides)IBA 04/2015 - 12/2003
4	Collagen Type II (Type II Collagen)IBA 04/2015 - 07/2003
4	OligodeoxyribonucleotidesIBA 08/2014 - 10/2003
4	Glucose (Dextrose)FDA LinkGeneric 01/2013 - 04/2005
3	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 12/2022 - 01/2013
3	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2021 - 12/2011
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2019 - 08/2012
3	LipopolysaccharidesIBA 02/2019 - 01/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2017 - 01/2013
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2017 - 01/2010
3	ApaminIBA 04/2015 - 02/2010
3	G(M3) GangliosideIBA 08/2014 - 01/2013
3	caffeic acid phenethyl esterIBA 08/2014 - 11/2004
3	Triglycerides (Triacylglycerol)IBA 06/2012 - 10/2006
3	ProteomeIBA 10/2009 - 10/2006
2	Small Interfering RNA (siRNA)IBA 08/2023 - 08/2006
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 03/2007
2	AntioxidantsIBA 01/2021 - 03/2007
2	Actins (F Actin)IBA 10/2020 - 01/2019
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2019 - 01/2018
2	CaspasesIBA 12/2018 - 01/2017
2	IsothiocyanatesIBA 09/2017 - 12/2015
2	phenethyl isothiocyanate (PEITC)IBA 09/2017 - 12/2015
2	HexanesIBA 01/2017 - 07/2013
2	EnzymesIBA 12/2015 - 11/2004
2	Therapeutic UsesIBA 06/2015 - 11/2004
2	Collagen Type I (Type I Collagen)IBA 01/2014 - 08/2006
2	Plasminogen Activator Inhibitor 1IBA 01/2014 - 10/2009
2	FlavonoidsIBA 06/2013 - 03/2007
2	Free RadicalsIBA 01/2013 - 12/2006
2	Alanine Transaminase (SGPT)IBA 01/2010 - 05/2004
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2010 - 05/2004
2	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2009 - 05/2006
2	Interleukin-1beta (Interleukin 1 beta)IBA 05/2009 - 08/2003
2	Estrogen ReceptorsIBA 11/2007 - 04/2005
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2007 - 02/2004
2	Interleukin-1 (Interleukin 1)IBA 09/2006 - 08/2003
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 08/2006 - 05/2006
2	Glutamic Acid (Glutamate)FDA Link 04/2005 - 12/2003
2	Cathepsin KIBA 08/2004 - 11/2003
1	Deubiquitinating EnzymesIBA 04/2024
1	ginsenoside Rg3IBA 01/2024

Therapy/Procedure

9	Therapeutics 01/2020 - 04/2005
2	Traditional Medicine (Folk Remedies) 01/2017 - 04/2015
2	Oral Administration 11/2004 - 02/2004